The first meeting of the Pharmaceutical Commission of the Iran–India Joint Chamber of Commerce was held at the proposal of Golrang Pharmaceutical Investment co.(GPI co.).
The Golrang Drug and Health Innovation Center participated in the “Research and Technology Ecosystem of Tehran University of Medical Sciences” program on December 15–16, 2025
Faran Shimi Knowledge-Based Company, a subsidiary of Golrang Pharmaceutical Investment Group, has announced the official launch of OctaHeal Alpha‑Lipoic Acid 300 mg. According to the
Golrang Pharmaceutical Investment Group participated in the Afghan Health Exhibition with the aim of exporting pharmaceutical products and dietary supplements from its subsidiary companies. According
The second Golrang Pharmaceutical and Health Innovation Event was held on December 29, 2025 (8 Azar 1404), with the participation of Golrang judges and experts,
A joint meeting was held between the executives of Golrang Pharmaceutical Investment Group and the Director General and Senior Manager of the Africa Office of
Faran Shimi, a subsidiary of Golrang Pharmaceutical Group, has announced the official launch of the drug Macitentan in the country’s pharmaceutical market, as part of
The Ambassador of Uruguay visited the factories of Faran Shimi and Abian Darou Companies in Hamedan. According to the Public Relations Office of Golrang Pharmaceutical
At Iran’s first specialized nanomedicine startup event, three innovative projects—“Faisona” from Jiroft University of Medical Sciences, and “Hydracin” and “Vitadetect” from Tehran University of Medical
The second specialized conference on “Challenges of HSE in the Pharmaceutical, Cosmetics, Hygiene, and Detergent Industries” was held on Monday, October 6, 2025, at the
Three new pharmaceutical products were unveiled by the Golrang Pharmaceutical Investment Group during the 10th Iran Pharma International Exhibition. According to the Public Relations Department
Golrang Pharmaceutical Investment Group will showcase its pavilion at the 10th Iran Pharma Exhibition 2025, featuring the participation of 14 subsidiary companies. According to the
